NewKerala.com

Key Points

A US court sentenced ex-McKinsey partner Martin Elling to six months for obstructing justice by deleting documents tied to Purdue Pharma’s opioid sales strategy. Elling helped devise McKinsey’s plan to aggressively market OxyContin, including targeting high-prescribing doctors. His 2018 emails revealed deliberate efforts to destroy evidence as lawsuits mounted. The case follows McKinsey’s $650 million settlement with the DOJ over its role in the opioid crisis.

Key Points: Ex-McKinsey Partner Martin Elling Gets Prison for Purdue Pharma Cover-Up

  • Elling destroyed evidence amid Purdue Pharma lawsuits
  • McKinsey paid $650M DOJ settlement
  • Advised Sacklers on boosting OxyContin sales
  • Targeted high-prescribing doctors in sales strategy
2 min read

Martin Elling, Ex-McKinsey partner sentenced to prison for obstructing justice by a US court

Former McKinsey partner sentenced to 6 months for destroying documents tied to Purdue Pharma’s OxyContin scandal after $650M DOJ settlement.

"Eliminate all our documents and emails – Martin Elling in 2018 internal email"

New Delhi, May 23

Martin Elling, former partner at McKinsey & Co., received a six-month prison sentence for obstructing justice, Reuters reported on Thursday.The ex- McKinsey partner was involved in destruction of documents related to the consulting firm's advice to Purdue Pharma on how to aggressively increase sales of their opioid painkiller, OxyContin.

As reported by Reuters, U.S. District Judge Robert Ballou delivered the sentence in Abingdon, Virginia, after McKinsey's December agreement to pay USD 650 million to settle related charges from the U.S. Department of Justice regarding their work for Purdue.

Prosecutors in the case had sought a one-year prison term after Elling's guilty plea in January. His lawyer argued that any jail time would be "devastating" and bar him from living in his new residence in Thailand. A representative for Elling's legal team confirmed the sentence and stated that he is apologetic for his actions.

Purdue Pharma itself admitted guilt in 2020 to charges related to the misconduct related to its marketing and sale of its prescription painkillers. Elling played a role in securing McKinsey's work with Purdue in 2013, which led to the New York-based firm developing a strategy to significantly increase OxyContin sales.

Prosecutors detailed that this strategy involved targeting "high-value" medical professionals, including those who prescribed opioids inappropriately. Court documents revealed that Elling was among a small group of McKinsey partners who attended a 2013 meeting with the Sackler family, the owners of Purdue Pharma, who ultimately approved McKinsey's proposal.

In July 2018, after learning about a lawsuit filed against Purdue by the Massachusetts attorney general, Elling emailed a McKinsey colleague questioning whether they should "eliminate all our documents and emails." The following month, Elling emailed himself a reminder to "delete old pur (Purdue Pharma) documents from laptop," and prosecutors stated that a forensic analysis confirmed he did so.

- ANI

Share this article:

Reader Comments

R
Rajesh K.
This case shows how corporate greed can destroy lives. In India too we've seen pharma companies push unnecessary medicines. The 6-month sentence seems too light considering how many families were ruined by OxyContin. White-collar crimes need stricter punishment globally. 🇮🇳
P
Priya M.
As someone working in corporate ethics, this case is shocking! McKinsey is supposed to be a respected name. Hope Indian consulting firms learn from this - destroying evidence is never the solution. The Thailand residence angle seems like he was trying to escape consequences.
A
Amit S.
The opioid crisis has affected millions. While the punishment is less than what prosecutors wanted, at least there's some accountability. In India, we need stronger whistleblower protections so such malpractices can be reported without fear.
S
Sunita R.
Very disturbing to read how they targeted doctors who were overprescribing. This is why we need stricter pharma regulations in India too. Big companies often put profits before people's health. The $650 million settlement won't bring back the lives lost to addiction.
V
Vikram J.
While the crime is serious, we should also consider that one mistake shouldn't define a person's entire career. If he's genuinely remorseful, rehabilitation should be part of the process. But yes, corporate accountability is crucial - hope Indian courts take note of such cases.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50